Related Experiment Videos
Liver transplantation for cholesteryl ester storage disease
G D Ferry1, H H Whisennand, M J Finegold
1Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Journal of Pediatric Gastroenterology and Nutrition
|April 1, 1991
Summary
Liver transplantation successfully treated a patient with cholesteryl ester storage disease, resolving cirrhosis and bleeding. Post-transplant, the patient shows improved growth and normalized cholesterol, with manageable hypersplenism and elevated kidney markers.
Area of Science:
- Hepatology
- Transplantation Medicine
- Metabolic Disorders
Background:
- Cholesteryl ester storage disease (CESD) is a rare genetic disorder causing progressive liver damage.
- Patients often develop complications like cirrhosis, portal hypertension, and gastrointestinal bleeding.
- Liver transplantation is a potential treatment for end-stage liver disease due to CESD.
Observation:
- A patient with CESD underwent liver transplantation due to severe cirrhosis and related complications.
- Post-transplantation follow-up assessed clinical status, biochemical markers, and disease progression.
- Key parameters monitored included growth, lipid profiles, liver function, and organ-specific complications.
Findings:
- The patient experienced significant clinical improvement, including enhanced growth and normalized cholesterol levels.
- Cirrhosis and gastrointestinal bleeding resolved post-transplantation.
- Mild hypersplenism and elevated blood urea nitrogen (BUN) and creatinine persisted, alongside elevated triglycerides, but without signs of progressive disease in other organs.
Implications:
- Liver transplantation can be an effective treatment for end-stage liver disease caused by CESD.
- Long-term management requires monitoring for potential post-transplant complications such as renal dysfunction and persistent hypertriglyceridemia.
- This case highlights the potential for successful outcomes and improved quality of life in CESD patients following liver transplantation.